- Home
- SGC vs TSVT Comparison
SGC vs TSVT Comparison
Compare SGC & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGC
- TSVT
- Stock Information
- Founded
- SGC 1920
- TSVT 2021
- Country
- SGC United States
- TSVT United States
- Employees
- SGC N/A
- TSVT N/A
- Industry
- SGC Apparel
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- SGC Consumer Discretionary
- TSVT Health Care
- Exchange
- SGC Nasdaq
- TSVT Nasdaq
- Market Cap
- SGC 281.4M
- TSVT 160.4M
- IPO Year
- SGC N/A
- TSVT N/A
- Fundamental
- Price
- SGC $16.42
- TSVT $3.07
- Analyst Decision
- SGC Strong Buy
- TSVT Buy
- Analyst Count
- SGC 2
- TSVT 6
- Target Price
- SGC $22.50
- TSVT $10.40
- AVG Volume (30 Days)
- SGC 46.5K
- TSVT 270.9K
- Earning Date
- SGC 11-06-2024
- TSVT 11-12-2024
- Dividend Yield
- SGC 3.40%
- TSVT N/A
- EPS Growth
- SGC 79.86
- TSVT N/A
- EPS
- SGC 0.82
- TSVT N/A
- Revenue
- SGC $567,509,000.00
- TSVT $45,620,000.00
- Revenue This Year
- SGC $5.21
- TSVT N/A
- Revenue Next Year
- SGC $4.02
- TSVT $36.09
- P/E Ratio
- SGC $20.08
- TSVT N/A
- Revenue Growth
- SGC 4.19
- TSVT N/A
- 52 Week Low
- SGC $11.66
- TSVT $2.78
- 52 Week High
- SGC $21.80
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- SGC 43.16
- TSVT 32.27
- Support Level
- SGC $16.51
- TSVT $2.78
- Resistance Level
- SGC $17.40
- TSVT $4.07
- Average True Range (ATR)
- SGC 0.51
- TSVT 0.24
- MACD
- SGC -0.12
- TSVT -0.05
- Stochastic Oscillator
- SGC 0.00
- TSVT 12.02
About SGC Superior Group of Companies Inc.
Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.